The Value of BCG and TNF in Autoimmunity
- Publisher's listprice EUR 131.00
-
51 168 Ft (48 732 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 117 Ft off)
- Discounted price 46 052 Ft (43 859 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
51 168 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 2
- Publisher Elsevier Science
- Date of Publication 19 July 2018
- ISBN 9780128146033
- Binding Paperback
- No. of pages200 pages
- Size 228x152 mm
- Weight 340 g
- Language English 0
Categories
Long description:
The Value of BCG and TNF in Autoimmune Diseases, Second Edition provides an overview on the current research related to TNF induction and the use of the BCG vaccine as a potential treatment approach to diverse forms of autoimmunity, allergies, infections and neurologic diseases. Since the initial conference (2013) and first edition of this book (2014), the field of BCG research has grown considerably. This new edition contains updates on MS and diabetes, and features at least eight additional chapters on new prevention and treatment trials in autoimmunity and allergy, along with a new understanding of the genetics of BCGs.
MoreTable of Contents:
1. BCG: Its Impact on Tuberculosis and Relevance to Autoimmune Disease
2. The Potential of TNF Induction from BCG for the Treatment of Type 1 Diabetes
3. Bacille Calmette-Gu-rin (BCG) Vaccine in Neuroinflammation
4. Host Epigenetic Modifications in Mycobacterium Tuberculosis Infection: A Boon or Bane
5. Mycobacterium Bovis Bacille Calmette-Guerin Vaccination: Can Biomarkers Predict Efficacy
6. The Heterologous Effects of Bacillus Calmette-Gu-rin (BCG) Vaccine and Trained Innate Immunity
7. BCG in Neonatals
8. Epigenetic Rewiring of Monocytes in BCG Vaccination
9. Mycobacteria, Immunoregulation and Autoimmunity
10. mTORC1 Links Cellular Metabolism and Immune Functions in Mycobacterium Tuberculosis Infection and BCG Vaccination
11. The Role of Maternal Priming and Boosting for the Non-Specific Effects of BCG Vaccine
